๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A prospective trial of recombinant human interferon alpha 2B in previously untreated patients with hepatocellular carcinoma

โœ Scribed by The Gastrointestinal Tumor Study Group


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
476 KB
Volume
66
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A Phase II trial of 5-fluorouracil and r
โœ Richard Pazdur; Jaffer A. Ajani; Rodger Winn; James Bearden; Robert J. Belt; Sus ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 468 KB ๐Ÿ‘ 2 views

A Phase I1 clinical trial of the combination of 5-fluorouracil (5-FU) and recombinant alpha-2a-interferon (a-2a-IFN) was conducted in 44 patients. Patients had not received chemotherapy previously and had measurable metastatic gastric carcinoma. 5-FU was administered as a continuous infusion at a do

Recombinant alpha-2b-interferon enhances
โœ Giovanni Scambia; Pierluigi Benedetti Panici; Stefano Iacobelli; Gabriela Baiocc ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 372 KB ๐Ÿ‘ 1 views

The circulating levels of a 90-kilodalton (K) tumor-associated antigen were measured in the blood of 43 patients with gynecologic and breast malignancies who underwent a short course of recombinant alpha-2b-interferon (rIFN a-zb) (3 million U/m2/d intramuscularly [IM] for 3 days). Of the 43 patients